Skip to main content

Table 3 Kaplan–Meier analysis for 5-year DFS based on 4 different subtypes on IR, BCS, and TM (log-rank test) in T≤3cm group

From: Long-term oncologic safety of immediate reconstructive surgery in patients with invasive breast cancer: a retrospective matched-cohort study

 

5-Y DFS

Median 5-Y DFS

P

%

Months

95%CI

Total

0.539

 IR

85.2%

57.73

56.65-58.80

 

 BCS

83.2%

57.16

55.87-58.46

 

 TM

80.6%

56.44

55.02-57.86

 

Luminal A

0.680

 IR

94.5%

59.42

58.66-60.18

 

 BCS

93.0%

59.23

58.36-60.10

 

 TM

90.2%

58.74

57.41-60.07

 

Luminal B

0.559

 IR

89.6%

58.67

57.44-59.91

 

 BCS

85.5%

57.75

56.05-59.45

 

 TM

83.6%

56.40

54.14-58.67

 

Her2 +

0.890

 IR

62.5%

53.89

48.88-58.91

 

 BCS

55.6%

52.11

46.12-58.09

 

 TM

61.1%

54.04

49.17-58.92

 

TN

0.738

 IR

58.8%

52.14

46.57-57.71

 

 BCS

72.2%

53.64

47.70-59.57

 

 TM

63.2%

52.69

47.22-58.16

 
  1. IR immediate reconstruction, BCS breast conservation surgery, TM total mastectomy, TN triple negative